Larimar Therapeutics Inc
(LRMR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 90,890 | 41,758 | 36,526 | 50,465 | 42,804 |
| Operating Income | -90,890 | -41,758 | -36,526 | -50,465 | -42,804 |
| Other Income | 10,286 | 4,809 | 1,171 | -171 | 322 |
| Pre-tax Income | -80,604 | -36,949 | -35,355 | -50,636 | -42,482 |
| Net Income Continuous | -80,604 | -36,949 | -35,355 | -50,636 | -42,482 |
| Net Income | $-80,604 | $-36,949 | $-35,355 | $-50,636 | $-42,482 |
| EPS Basic Total Ops | -1.32 | -0.84 | -1.37 | -2.95 | -3.57 |
| EPS Basic Continuous Ops | -1.32 | -0.84 | -1.37 | -2.95 | -3.58 |
| EPS Diluted Total Ops | -1.32 | -0.84 | -1.37 | -2.95 | -3.57 |
| EPS Diluted Continuous Ops | -1.32 | -0.84 | -1.37 | -2.95 | -3.58 |
| EPS Diluted Before Non-Recurring Items | -1.32 | -0.84 | -1.37 | -2.95 | -3.57 |
| EBITDA(a) | $-95,828 | $-43,290 | $-36,982 | $-50,153 | $-42,639 |